News

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.
I agree to the Terms of Use , Privacy Notice and Cookie Notice. I would like to receive updates and special offers from Dow ...
I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
Shares of Novo Nordisk (NVO) are rising early Monday after the US Food and Drug Administration approved Wegovy to treat ...
Over the past five years, the stock has displayed a recurring pattern of negative one-day returns after earnings.
Symbotic’s Q3 was soft beyond Walmart gains, with weak growth, flat backlog, and high valuation amplifying customer risk.
On fundamentals, Medtronic’s current market capitalization is $119 billion. Over the last twelve months, the company ...
Among Nvidia, Microsoft, Apple, Alphabet, Amazon, Meta Platforms, and Tesla are two sensational businesses that can become ...
Current and former OpenAI employees plan to sell approximately $6 billion worth of shares to an investor group that includes ...
American Water Works, a utility company that provides water and wastewater services in the IS, is now a $28 billion (by ...